Unapproved marketing of pressure ulcer drug brings settlement worth up to $48 million
By
McKnight's Staff
Dec 10, 2012
The unapproved bed sore drug Xenaderm, which was marketed to nursing homes as “Medicaid reimbursed,” is the source of a settlement that could reach $48 million for Healthpoint Ltd. and DFB...
